The investment seeks to track the investment results of the MSCI EAFE IMI Index composed of large-, mid- and small-capitalization developed market equities, excluding the U... Show more
The iShares Core MSCI EAFE ETF (IEFA) seeks to track the MSCI EAFE Investable Market Index (IMI), a free float-adjusted, market capitalization-weighted benchmark that measures the performance of large-, mid-, and small-cap equities across 21 developed markets in Europe, Australasia, and the Far East, excluding the U.S. and Canada. This passive fund employs a representative sampling strategy to replicate the index, holding approximately 2,633 securities for broad diversification.
Top holdings as of early 2026 include ASML Holding NV (2.18%), Roche Holding Par AG (1.30%), AstraZeneca PLC (1.26%), Novartis AG (1.25%), and HSBC Holdings PLC (1.19%), with the top 10 comprising about 11.6% of assets. Sector allocations emphasize financials at 22.49%, industrials at 20.53%, healthcare at 10.31%, and information technology at 8.68%. The expense ratio is a competitive 0.07%, and the fund rebalances in line with the index's semi-annual reviews, maintaining low portfolio turnover around 3%.
Developed markets ex-U.S. encompass mature economies in Europe, Japan, Australia, and others, characterized by established financial systems, advanced manufacturing, and healthcare innovation. Structural growth drivers include Japan's corporate reforms boosting shareholder returns, Europe's green energy transition, and Australia's commodity resilience. Recent capital flows have shifted toward these regions amid U.S. valuation concerns, fueled by macroeconomic factors like anticipated rate cuts from the ECB and Bank of Japan policy normalization.
Catalysts encompass robust earnings from industrials and financials, supportive fiscal stimuli in Germany and the U.K., and regulatory pushes for AI infrastructure in semiconductors. Risks involve geopolitical strains such as U.S.-EU trade frictions, persistent inflation in energy importers, and slowing GDP growth in aging populations. Overall, the landscape favors diversified exposure as global supply chains realign.
In recent market cycles, IEFA has demonstrated resilience, posting strong gains over the past year driven by sector rotation into financials and industrials amid cooling U.S. tech dominance. Year-to-date through early 2026, the fund advanced notably, building on 2025's robust performance amid favorable macro data like easing inflation and currency tailwinds from a softer dollar. Over three years, annualized returns reflect steady compounding, connecting to earnings beats in key holdings and broader international catch-up versus U.S. benchmarks.
The ETF's positioning benefits from its mid- and small-cap inclusion, capturing upside in cyclical recoveries tied to global trade stabilization and commodity price steadiness. Volatility remains moderate, with beta around 0.8 relative to broader equities, underscoring its role in portfolio balancing during rotation phases.
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI-driven trading bots under prevailing market conditions. Tickeron provides hundreds of AI bots scanning thousands of tickers across diverse strategies, timeframes, and performance metrics, from momentum and mean reversion to options trading. Only the strongest, real-time performers rise to this curated section, helping investors identify tools aligned with current volatility or trends like international rotation. Explore bots tailored for ETFs such as IEFA, with transparent win rates, Sharpe ratios, and backtested results. Visit the page to discover leading options and enhance your trading edge professionally.
Looking to 2026, IEFA's exposure positions it to capture structural trends in developed ex-U.S. markets, including accelerated GDP growth projected around 1.2% across key constituents, up from prior years, alongside earnings cycles in top holdings like ASML and Novartis. Policy shifts, such as potential U.S. tariff negotiations and ECB fiscal expansions, could drive capital inflows, while Japan's wage gains support consumer sectors.
Macro risks encompass renewed U.S. dollar appreciation curbing returns and geopolitical escalations in Europe disrupting industrials. Competitive dynamics intensify with peers like VXUS, but IEFA's low costs and comprehensive IMI coverage maintain appeal. Monitor semiconductor demand for tech weights, energy transition policies impacting utilities, and global rate paths influencing financials. Balanced positioning across cyclicals and defensives offers resilience amid evolving trade flows and AI capex spillover, emphasizing long-term diversification without chasing short-term swings.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
IEFA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where IEFA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 15, 2026. You may want to consider a long position or call options on IEFA as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for IEFA just turned positive on June 16, 2026. Looking at past instances where IEFA's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
IEFA moved above its 50-day moving average on June 11, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IEFA advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 317 cases where IEFA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeBlend